- Home
- SRV vs PROK Comparison
SRV vs PROK Comparison
Compare SRV & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRV
- PROK
- Stock Information
- Founded
- SRV 2007
- PROK 2015
- Country
- SRV United States
- PROK United States
- Employees
- SRV N/A
- PROK N/A
- Industry
- SRV Finance Companies
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRV Finance
- PROK Health Care
- Exchange
- SRV Nasdaq
- PROK Nasdaq
- Market Cap
- SRV N/A
- PROK 126.8M
- IPO Year
- SRV N/A
- PROK N/A
- Fundamental
- Price
- SRV $44.08
- PROK $0.84
- Analyst Decision
- SRV
- PROK Buy
- Analyst Count
- SRV 0
- PROK 4
- Target Price
- SRV N/A
- PROK $5.00
- AVG Volume (30 Days)
- SRV 33.9K
- PROK 434.6K
- Earning Date
- SRV 01-01-0001
- PROK 05-09-2025
- Dividend Yield
- SRV 13.38%
- PROK N/A
- EPS Growth
- SRV N/A
- PROK N/A
- EPS
- SRV N/A
- PROK N/A
- Revenue
- SRV N/A
- PROK $76,000.00
- Revenue This Year
- SRV N/A
- PROK N/A
- Revenue Next Year
- SRV N/A
- PROK N/A
- P/E Ratio
- SRV N/A
- PROK N/A
- Revenue Growth
- SRV N/A
- PROK N/A
- 52 Week Low
- SRV $30.73
- PROK $0.80
- 52 Week High
- SRV $44.30
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- SRV 49.39
- PROK 29.40
- Support Level
- SRV $43.00
- PROK $0.87
- Resistance Level
- SRV $44.90
- PROK $1.00
- Average True Range (ATR)
- SRV 0.86
- PROK 0.10
- MACD
- SRV 0.11
- PROK 0.01
- Stochastic Oscillator
- SRV 54.08
- PROK 14.70
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.